CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Michelle Glass

OPENALEX: A5052855527↗ORCID: 0000-0002-5997-6898↗

Affiliations

Organizations

Temple Universityauthorship · US University of Aucklandauthorship · NZ University of Otagoauthorship · NZ

Public evidence

6 connected articles

Insights into Cannabinoid Receptor 2 (CB2) anterograde trafficking and pharmacological chaperoning2025 · bioRxiv Cannabinoid Receptor 2 (CB <sub>2</sub> ) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes2019 · bioRxiv Insights into cannabinoid receptor 2 (CB2) anterograde trafficking and pharmacological chaperoning.2025 · Europe PMC Characterisation of AMB-FUBINACA metabolism and CB<sub>1</sub>-mediated activity of its acid metabolite.2023 · Europe PMC Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.2022 · Europe PMC Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors.2020 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Michelle Glass - Medical Cannabis Research Engine